Guidance aiming to ensure all inpatients on dexamethasone receive appropriate glucose surveillance and appropriate managements of hyperglycaemia has been released.
It is the latest instalment from the National Inpatient Diabetes COVID-19 Response Group, set up during the coronavirus crisis and chaired by Professor Gerry Rayman MBE.
According to studies, dexamethasone reduces mortality in people with COVID-19 who require ventilation or oxygen therapy, but the use of steroids can result in significant hyperglycaemia in people with diabetes and new onset diabetes in those previously undiagnosed.
The award-winning Low Carb Program has been recognised by The Times as the Best Health App for type 2 diabetes prevention.
Low Carb Program, developed by Diabetes Digital Media (DDM), was selected as the category leading app for type 2 diabetes self-management and remission in the Best Health Apps 2020 List published on July 7, 2020.
Roche Diabetes Care Trainers, looking for new ways to work with people with diabetes under current circumstances, have made a transition to using video conferencing tools to remotely help those who are beginning pump therapy.
Trainers in this role usually show patients and healthcare professionals how to use diabetes pumps and devices in a face to face setting, however, during lockdown, this usual route has proven difficult.
The Diabetes Times has launched a survey to gauge views as the diabetes community prepares for life post coronavirus.
There has been so much uncertainty since March when the country went into a national lockdown to combat the global pandemic, but as restrictions begin to ease life is gradually starting to get back to a ‘new normal’.
In response, we have decided to do this survey to find out a few insights from the lockdown and also to establish some common views on how we move forward into the autumn.
To take part in the survey, click here.
The “major findings” from the newly published DAPA-HF are to be exclusively discussed by the lead author himself as part of a series of online webinars.
The standout headline from the newly released findings by Professor John McMurray is that AstraZeneca’s dapagliflozin reduces new-onset diabetes by almost a third among adults with heart failure.
Professor Kamlesh Khunti is a pioneer in type 2 diabetes research and is ranked third among the top 10 of the world’s leading experts into the condition.
A co-founder of the Leicester Diabetes Centre and Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, he also tops the UK list of diabetes experts.
He is also Director of the National Institute for Health Research (NIHR) in Applied Research Collaborations (ARC) East Midlands and is a Trustee of the South Asian Health Foundation (SAHF).
Leading experts will give primary care services a “helping hand” to better understand a specific type 2 diabetes medication.
Leicester researchers have published a new training programme module to help GPs and community nurses know more about glucagon-like peptide 1 receptor agonists (GLP-1 RAs). To read more, click here.
Artificial intelligence could help prevent eye damage and sight loss in people with diabetes.
Results from the largest study of artificial intelligence use in the English Diabetic Eye Screening Programme (DESP), have shown the technology can accurately detect serious eye disease among those with diabetes. To read more, click here.
Using a FreeStyle Libre halves the risk of being admitted to hospital with diabetic ketoacidosis (DKA), according to researchers.
More than 74,000 people took part in the RELIEF study, of which 33,000 had type 1 diabetes and the rest had type 2. To read more, click here.
Libre reduces type 2 diabetes HbA1c levels
Newly published research has shown the FreeStyle Libre reduces HbA1c levels for people with type 2 diabetes on either long-acting insulin or non-insulin therapy.
The results were unveiled at the American Diabetes Association (ADA) 80th Scientific Sessions. To read more, click here.
Leading diabetes nurse consultant Debbie Hicks has joined a medtech start-up to advise on the further development of its remote diabetes management technology platforms.
The co-founder of Trend Diabetes will help Gendius. To read more, click here.
Bringing you the latest jobs from around the country within the field of diabetes.
Housebound Diabetes Specialist Nurse – East London Foundation NHS Foundation Trust
Diabetes Consultant – Chesterfield Royal Hospital NHS Foundation Trust
Senior Lecturer in Diabetes Care – Birmingham, City South Campus
gyConsultant in Diabetes & Endocrinolo – East Suffolk and North Essex NHS Foundation Trust
With thanks to our sponsors
Join the expanding diabetes community on Twitter and follow us for the latest diabetes news updates at @DiabetesTimes.
We are now on YouTube where you will find interviews with leading people within the field of diabetes. Click here to visit our page.
